• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35DC06012013IU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Calcium Deposits/Calcification (1758); Stenosis (2263); Claudication (2550)
Event Date 08/02/2017
Event Type  Injury  
Manufacturer Narrative
At the two year follow-up, a duplex ultrasound showed a calcified plaque in the treated lesion.As a result, the patient required revascularization using a pta balloon, stent implantation, and atherectomy.Availability to enter this information in section c is still work in progress at spnc, thus the drug information is noted below: stellarex 0.035 otw drug-coated angioplasty balloon, paclitaxel drug, 4.7 mg, therapy date: (b)(6) 2015, adjunct to pta in the treatment of denovo or post pta occluded/ stenotic or restenotic lesions (excluding in-stent) in fem-pop arteries, lot #: 15a2961202, expiration date: 08/05/2015.Udi and pma numbers are not applicable.This device was used in clinical application prior to being available in the us.Study name- (b)(6), patient (b)(6).Combination product is applicable.During the index procedure, the product worked as intended, thus no product evaluation was required.Per the ifu, restenosis is listed as a potential complications/adverse events.
 
Event Description
On (b)(6) 2015, the patient underwent the index procedure for treatment of a 140 mm, 90% stenotic denovo lesion in the right mid-sfa.The lesion was predilated initially with a 5 x 120 mm balloon at 8 atm and using a second 5 x 120 mm balloon which was inflated two times.Residual stenosis following predilatation was 60%.Next, a 6 x 120 mm stellarex balloon was inflated to 8 atm for 5 minutes.Then, a second stellarex 5 x 80 mm balloon was inflated to 6 atm for 5 minutes, resulting in a residual stenosis of 10%.No complications occurred and the subject was discharged as per plan on (b)(6) 2015.At the 2 year follow-up visit on (b)(6) 2017, a duplex ultrasound showed calcified plaque in the right mid sfa.On (b)(6) 2017, the patient complained of bilateral lower extremity claudication.On (b)(6) 2017, the patient underwent a successful revascularization procedure of the right mid sfa using pta, stent implantation and atherectomy.The physician has indicated that it is unlikely that the event is related to the device or procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
fremont CA
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
florie cazem
5055 brandin court
fremont, CA 94538
510933-792
MDR Report Key6815983
MDR Text Key83474795
Report Number3009784280-2017-00006
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 08/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/05/2015
Device Model NumberA35DC06012013IU
Device Catalogue NumberA35DC06012013IU
Device Lot Number15A2961202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2017
Initial Date FDA Received08/23/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MFG AND SIZE UNK: GUIDE CATHETER; MFG AND SIZE UNK: GUIDE WIRE; MFG AND SIZE UNK: INTRODUCER SHEATH
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight87
-
-